TM6SF2 and metabolic dysfunction-associated steatotic liver disease: As the AST and ALT are the significant liver injury biomarkers [46], our results suggested that TM6SF2 rs58542926 T allele was associated with the hepatic TG accumulation, therefore leads to the decreased serum lipid profiles, and promotes the liver injury in NAFLD patients.